Bentley Pharmaceuticals, Inc.

As of July 22, 2008, Bentley Pharmaceuticals, Inc. was acquired by Teva Pharmaceutical Industries Limited. Bentley Pharmaceuticals, Inc., through its subsidiaries, engages in the research, development, licensing, and commercialization of generic and branded pharmaceutical products, active pharmaceutical ingredients, and drug delivery technologies. It offers pharmaceuticals for the treatment of cardiovascular, gastrointestinal, infectious, and central nervous system diseases in Europe. The company was founded in 1974 and is headquartered in Exeter, New Hampshire.